Evolution of Cerebrovascular Imaging and Associated Clinical Findings in Children with Alagille Syndrome

Overview

Journal Neuroradiology

Specialties Neurology
Radiology

Date 2024 Feb 24

PMID 38400955

Authors

Carmen Rosa Cerron-Vela

Luis Octavio Tierradentro-Garcia

Zekordavar Lavadka Rimba

Savvas Andronikou

Affiliations

Soon will be listed here.

Abstract

Purpose: Alagille syndrome (ALGS) is a multisystem autosomal dominant disorder with highly variable expression. Intracranial arterial and venous anomalies have a reported prevalence of 30-40% and can increase the risk of stroke by 16%. Few reports document the frequency and evolution of cerebrovascular abnormalities (CVAs) in children with ALGS. We aimed to define the spectrum, frequency, and evolution of CVAs in a series of children with ALGS using magnetic resonance angiography (MRA).

Methods: We conducted a single-center, retrospective study in a large tertiary pediatric hospital. CVAs were grouped into 4 categories: 1) Stenosis or narrowing; 2) Aneurysms and ectasias; 3) Tortuosity; and 4) Vascular anomalies and anatomical variants.

Results: Thirty-two children met the inclusion criteria. The median age at initial diagnosis was 6 (3.8-10.3) years. Thirteen (40%) had follow-up MRI at a mean of 55 (31.5-66) months. Eighteen (56%) had CVAs; the most frequent fell into group 1 (n = 12, 37.5%). CVAs were stable over time, except for one patient with Moyamoya arteriopathy (MMA). One patient developed a transient ischemic attack secondary to an embolic event. Three (9.3%) had microhemorrhages at the initial diagnosis secondary to Tetralogy of Fallot. Another patient had recurrent subdural hematomas of unknown cause.

Conclusion: CVAs were stable except in the presence of MMA. Vascular strokes, which are reported in older patients with ALGS, were not a common feature in children under 16 years of age, either at presentation or over the 31.5-66 month follow-up period.

References

Chen Y, Sun M, Teng X . Clinical and genetic analysis in Chinese children with Alagille syndrome. BMC Pediatr. 2022; 22(1):688. PMC: 9706830. DOI: 10.1186/s12887-022-03750-z. View

Kohut T, Gilbert M, Loomes K . Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment. Semin Liver Dis. 2021; 41(4):525-537. DOI: 10.1055/s-0041-1730951. View

Carpenter C, Linscott L, Leach J, Vadivelu S, Abruzzo T . Spectrum of cerebral arterial and venous abnormalities in Alagille syndrome. Pediatr Radiol. 2018; 48(4):602-608. DOI: 10.1007/s00247-017-4043-2. View

DAmico A, Perillo T, Cuocolo R, Ugga L, Di Dato F, Caranci F . Neuroradiological findings in Alagille syndrome. Br J Radiol. 2021; 95(1129):20201241. PMC: 8722249. DOI: 10.1259/bjr.20201241. View

Mitchell E, Gilbert M, Loomes K . Alagille Syndrome. Clin Liver Dis. 2018; 22(4):625-641. DOI: 10.1016/j.cld.2018.06.001. View

Rock N, Demaret T, Stephenne X, Scheers I, Smets F, McLin V . Intracranial Hypertension and Papilledema in a Large Cohort of Pediatric Patients With Alagille Syndrome. J Pediatr Gastroenterol Nutr. 2020; 71(5):655-662. DOI: 10.1097/MPG.0000000000002883. View

Fiorda-Diaz J, Shabsigh M, Dimitrova G, Soghomonyan S, Sandhu G . Perioperative Management of Subarachnoid Hemorrhage in a Patient with Alagille Syndrome and Unrepaired Tetralogy of Fallot: Case Report. Front Surg. 2017; 4:72. PMC: 5723013. DOI: 10.3389/fsurg.2017.00072. View

OConnell D, Kaliaperumal C, Fanning N, Wyse G, Kaar G . Superior cerebellar aneurysm causing subarachnoid haemorrhage in a 17-year-old with alagille syndrome. Br J Neurosurg. 2011; 26(2):287-9. DOI: 10.3109/02688697.2011.614022. View

Rocha R, Soro I, Leitao A, Silva M, Leao M . Moyamoya vascular pattern in Alagille syndrome. Pediatr Neurol. 2012; 47(2):125-8. DOI: 10.1016/j.pediatrneurol.2012.04.014. View

10.

Emerick K, Krantz I, Kamath B, Darling C, Burrowes D, Spinner N . Intracranial vascular abnormalities in patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2005; 41(1):99-107. DOI: 10.1097/01.mpg.0000162776.67758.2f. View

11.

Kamath B, Spinner N, Emerick K, Chudley A, Booth C, Piccoli D . Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004; 109(11):1354-8. DOI: 10.1161/01.CIR.0000121361.01862.A4. View

12.

Connor S, Hewes D, Ball C, Jarosz J . Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst. 2002; 18(3-4):186-90. DOI: 10.1007/s00381-001-0518-3. View

13.

Emerick K, Rand E, Goldmuntz E, Krantz I, Spinner N, Piccoli D . Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999; 29(3):822-9. DOI: 10.1002/hep.510290331. View

14.

Woolfenden A, Albers G, Steinberg G, Hahn J, Johnston D, Farrell K . Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. Pediatrics. 1999; 103(2):505-8. DOI: 10.1542/peds.103.2.505. View

15.

Moreau S, Bourdon N, Jokic M, de Rugy M, Babin E, Valdazo A . Alagille syndrome with cavernous carotid artery aneurysm. Int J Pediatr Otorhinolaryngol. 1999; 50(2):139-43. DOI: 10.1016/s0165-5876(99)00223-2. View

16.

Rachmel A, Zeharia A, Weitz R, Shamir R, Dinari G . Alagille syndrome associated with moyamoya disease. Am J Med Genet. 1989; 33(1):89-91. DOI: 10.1002/ajmg.1320330112. View

17.

Turnpenny P, Ellard S . Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2011; 20(3):251-7. PMC: 3283172. DOI: 10.1038/ejhg.2011.181. View

18.

ShenTu Y, Mi X, Tang D, Jiang Y, Gao L, Ma X . Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes. Clin Chim Acta. 2021; 521:258-263. DOI: 10.1016/j.cca.2021.07.026. View

19.

Doberentz E, Kuchelmeister K, Madea B . Subarachnoid hemorrhage due to aneurysm rupture in a young woman with Alagille syndrome - A rare cause of sudden death. Leg Med (Tokyo). 2015; 17(5):309-12. DOI: 10.1016/j.legalmed.2015.03.004. View

20.

Delaney S, OConnor G, Reardon W, Murphy S, Tierney S, Ryan B . Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille Syndrome. Front Neurol. 2019; 9:1194. PMC: 6362309. DOI: 10.3389/fneur.2018.01194. View